La vendita allo scoperto per Sabre Gold Mines Corp dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Sabre Gold Mines Corp. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Sabre Gold Mines Corp (OTC:SGLDF) Azioni, Report sulle vendite allo scoperto

Sabre Gold Mines Corp

Cherry Hill Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHMI#NYSE">CHMI</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.10 by 70 percent. This is a 30.77 percent increase over earnings of $0.13 per share from the same period last year.

Earnings

Earnings Beats

News

CHMI

Cherry Hill Mortgage Q1 Adj. EPS $0.17 Beats $0.10 Estimate

WIIM

EOSE

Eos Energy Enterprises shares are trading higher after the company reported better-than-expected Q1 financial results.

Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.36 by 22.22 percent. This is a 16.98 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $195.50 million which beat the analyst consensus estimate of $187.56 million by 4.23 percent. This is a 7.78 percent decrease over sales of $212.00 million the same period last year.

HLIO

Helios Technologies Q1 Adj. EPS $0.44 Beats $0.36 Estimate, Sales $195.50M Beat $187.56M Estimate

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) sees Q2 sales of $7.100 billion-$7.700 billion vs $7.24 billion analyst estimate.

Guidance

Advanced Micro Devices Sees Q2 Sales $7.100B-$7.700B vs $7.24B Est

Mercury General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCY#NYSE">MCY</a>) reported quarterly losses of $(2.29) per share which beat the analyst consensus estimate of $(3.25) by 29.54 percent. This is a 393.59 percent decrease over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $1.39 billion which missed the analyst consensus estimate of $1.47 billion by 5.48 percent. This is a 9.42 percent increase over sales of $1.27 billion the same period last year.

Earnings Misses

Mercury General Q1 Adj. EPS $(2.29) Beats $(3.25) Estimate, Sales $1.39B Miss $1.47B Estimate

Completes $300 million January 2024 Board-authorized share repurchase program
Reflects operational excellence through Growth with Purpose strategy, robust cash generation and disciplined capital allocation
Adtalem Global Education Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NYSE">ATGE</a>), the leading healthcare educator in the United States, today announced that its board of directors has authorized a new share repurchase program, which allows Adtalem to repurchase up to $150 million of its common stock through May 2028.

Buybacks

Adtalem Global Education Inc. Common Stock

ATGE

Adtalem Global Education Board Authorizes New $150M Share Repurchase Program

Cadre Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDRE#NYSE">CDRE</a>) raises FY2025 sales outlook from $572.00 million-$601.00 million to $618.00 million-$648.00 million vs $607.77 million estimate.

CDRE

Cadre Hldgs Raises FY2025 Sales Guidance from $572.00M-$601.00M to $618.00M-$648.00M vs $607.77M Est

Jack Henry &amp; Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>) raises FY2025 GAAP EPS guidance from $5.78-$5.87 to $6.00-$6.09 vs $5.85 analyst estimate. Lowers FY2025 sales outlook from $2.37 billion-$2.39 billion to $2.35 billion-$2.37 billion vs $2.37 billion estimate.

JKHY

Jack Henry & Associates Raises FY2025 GAAP EPS Guidance from $5.78-$5.87 to $6.00-$6.09 vs $5.85 Est; Lowers FY2025 Sales Guidance from $2.37B-$2.39B to $2.35B-$2.37B vs $2.37B Est

Jack Henry &amp; Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>) raises FY2025 Adj EPS guidance from $5.65-$5.74 to $5.83-$5.87 vs $5.85 analyst estimate. Lowers FY2025 sales outlook from $2.35 billion-$2.38 billion to $2.33 billion-$2.34 billion vs $2.37 billion estimate.

Jack Henry & Associates Raises FY2025 Adj EPS Guidance from $5.65-$5.74 to $5.83-$5.87 vs $5.85 Est; Lowers FY2025 Sales Guidance from $2.35B-$2.38B to $2.33B-$2.34B vs $2.37B Est

Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) affirms FY2025 sales outlook from $90.00 million-$110.00 million to $90.00 million-$110.00 million.

DRCT

Direct Digital Holdings Affirms FY2025 Sales Guidance of $90.00M-$110.00M

AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.44 by 2.27 percent. This is a 15.38 percent increase over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $452.23 million which beat the analyst consensus estimate of $444.40 million by 1.76 percent. This is a 8.08 percent increase over sales of $418.41 million the same period last year.

AZEK

AZEK Co Q2 Adj. EPS $0.45 Beats $0.44 Estimate, Sales $452.23M Beat $444.40M Estimate

Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.01) by 3400 percent. This is a 59.09 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $8.16 million which missed the analyst consensus estimate of $9.40 million by 13.18 percent. This is a 63.38 percent decrease over sales of $22.27 million the same period last year.

Direct Digital Holdings Q1 EPS $(0.35) Misses $(0.01) Estimate, Sales $8.16M Miss $9.40M Estimate

BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 45.83 percent increase over losses of $(0.48) per share from the same period last year.

BCAB

BioAtla Q1 EPS $(0.26) Beats $(0.31) Estimate

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.94 by 2.13 percent. This is a 54.84 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $7.44 billion which beat the analyst consensus estimate of $7.13 billion by 4.38 percent. This is a 35.90 percent increase over sales of $5.47 billion the same period last year.

Advanced Micro Devices Q1 Adj. EPS $0.96 Beats $0.94 Estimate, Sales $7.44B Beat $7.13B Estimate

FLYW

Flywire shares are trading higher after the company reported a year-over-year increase in Q1 EPS results and better-than-expected sales results.

Kulicke &amp; Soffa Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>) Q3 expected to be more than $0.05 vs $0.35 Est. Q3 Revenue expected to be more than $145.00M vs $190.68M Est

KLIC

Kulicke & Soffa Indus Q3 EPS $0.05 +/- 10% vs $0.35 Est; Q3  Revenue $145.00M +/- $10M vs $190.68M Est

Cadre Hldgs Q1 EPS $0.23 Beats $0.15 Estimate, Sales $130.10M Beat $122.09M Estimate

Lucid Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.23) by 13.04 percent. This is a 25.93 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $235.05 million which missed the analyst consensus estimate of $250.00 million by 5.98 percent. This is a 36.07 percent increase over sales of $172.74 million the same period last year.

LCID

Lucid Gr Q1 Adj. EPS $(0.20) Beats $(0.23) Estimate, Sales $235.05M Miss $250.00M Estimate

Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) affirms FY2025 sales outlook from $465.00 million-$485.00 million to $465.00 million-$485.00 million vs $472.33 million estimate.

PRPL

Purple Innovation Affirms FY2025 Sales Guidance of $465.00M-$485.00M vs $472.33M Est

National CineMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCMI#NASDAQ">NCMI</a>) sees Q2 sales of $56.000 million-$61.000 million vs $68.53 million analyst estimate.

Comments

Sabre Gold Mines Corp

Vendite allo scoperto

Sabre Gold Mines Corp (OTC:SGLDF) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO